Teijin Establishes Investment Wing In Shanghai
This article was originally published in PharmAsia News
Executive Summary
To pursue strategic mergers and acquisitions in China and expand its business via investment in the Chinese market, Tokyo-based Teijin established an investment subsidiary in Shanghai